Rapidly growing mycobacteria in Singapore, 2006-2011

Clinical Microbiology and Infection

Volumn 21, Issue 3, 2015, Pages 236-241

  Tang, S S ^a   Lye, D C ^b   Jureen, R ^c   Sng, L H ^a   Hsu, L Y ^c  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b TAN TOCK SENG HOSPITAL   (Singapore)

^c NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

Antimicrobial susceptibility; Mycobacterium abscessus; Mycobacterium fortuitum group; Nontuberculous mycobacteria; Rapidly growing mycobacteria

Indexed keywords

AMIKACIN; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; IMIPENEM; LINEZOLID; MOXIFLOXACIN; QUINOLONE DERIVATIVE; SULFAMETHOXAZOLE; TIGECYCLINE; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; ATYPICAL MYCOBACTERIUM; BACTERIAL GROWTH; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLOOD ANALYSIS; EPIDEMIOLOGICAL DATA; HUMAN; IN VITRO STUDY; LABORATORY TEST; LYMPHADENITIS; MAJOR CLINICAL STUDY; MICROBIOLOGY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM FORTUITUM; PRIORITY JOURNAL; RAPIDLY GROWING MYCOBACTERIUM; RESPIRATORY SYSTEM; SINGAPORE; SKIN INFECTION; SOFT TISSUE INFECTION; CLASSIFICATION; COHORT ANALYSIS; DRUG EFFECTS; GENETICS; HISTORY; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MYCOBACTERIUM INFECTIONS;

CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM FORTUITUM;

ANTI-BACTERIAL AGENTS; COHORT STUDIES; DRUG RESISTANCE, BACTERIAL; HISTORY, 21ST CENTURY; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; SINGAPORE;

EID: 84933519411     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2014.10.018     Document Type: Article

References (21)

1. Cassidy P.M., Hedberg K., Saulson A., McNelly E., Winthrop K.L. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis 2009, 49:e124-e129.
2. Thomson R.M. Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis 2010, 16:1576-1583.
3. Simons S., Van Ingen J., Hsueh P., et al. Nontuberculous mycobacteria in respiratory tract infections, Eastern Asia. Emerg Infect Dis 2011, 17:343-349.
4. Yang S.C., Hsueh P.R., Lai H.C., et al. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan. Antimicrob Agents Chemother 2003, 47:1958-1962.
5. Brown-Elliott B.A., Nash K.A., Wallace R.J. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev 2012, 25:545-582.
6. Jarand J., Levin A., Zhang L., Huitt G., Mitchell J.D., Daley C.L. Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. Clin Infect Dis 2011, 52:565-571.
7. Griffith G.E., Aksamit T., Brown-Elliott B.A., et al. An official ATS/IDSA statement: diagnosis, treatment and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175:367-416.
8. Chen H.Y., Chen C.Y., Huang C.T., et al. Skin and soft-tissue infection caused by non-tuberculous mycobacteria in Taiwan, 1997-2008. Epidemiol Infect 2011, 139:121-129.
9. O'Brien D.P., Currie B.J., Krause V.L. Nontuberculous mycobacterial disease in Northern Australia: a case series and review of the literature. Clin Infect Dis 2000, 31:958-968.
10. Manual of clinical microbiology 2007, ASM Press, Washington, DC. 9th ed. P.R. Murray, E.J. Baron, J.H. Jorgensen (Eds.).
11. National Committee for Clinical Laboratory Standards Susceptibility testing of mycobacteria, Nocardiae, and other aerobic actinomycetes. Approved Standard M24-A 2011, National Committee for Clinical Laboratory Standards, Wayne, PA.
12. Department of Statistics, Singapore. Population and population structure. Available at: . [Accessed 21 July 2014]. http://www.singstat.gov.sg/statistics/browse_by_theme/population.html.
13. Teo S.K., Lo K.L. Nontuberculous mycobacterial disease of the lungs in Singapore. Singapore Med J 1992, 33:464-466.
14. Ding L.W., Lai C.C., Lee L.N., Hsueh P.R. Disease caused by non-tuberculous mycobacteria in a university hospital in Taiwan, 1997-2003. Epidemiol Infect 2006, 134:1060-1067.
15. Chen C.Y., Chen H.Y., Chou C.H., Huang C.T., Lai C.C., Hsueh P.R. Pulmonary infection caused by nontuberculous mycobacteria in a medical center in Taiwan, 2005-2008. Diagn Microbiol Infect Dis 2012, 72:47-51.
16. Yano Y., Kitada S., Mori M., et al. Pulmonary disease caused by rapidly growing mycobacteria: a retrospective study of 44 cases in Japan. Respiration 2013, 85:305-311.
17. Fernandez-Roblas R., Martin-de-Hijas N.Z., Fernandez-Martinez A.I., García-Almeida D., Gadea I., Esteban J. Invitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria. Antimicrob Agents Chemother 2008, 52:4184-4186.
18. Shen G.H., Wu B.D., Wu K.M., Chen J.H. Invitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan. Antimicrob Agents Chemother 2007, 51:1849-1851.
19. Huang T.S., Liu Y.C., Sy C.L., Chen Y.S., Tu H.Z., Chen B.C. Invitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years. Antimicrob Agents Chemother 2008, 52:2226-2227.
20. Van Ingen J., Boeree M.J., Van Soolingen D., Mouton J.W. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria. Drug Resist Updat 2012, 15:149-161.
21. Escribano I., Rodriguez J.C., Llorca B., García-Pachon E., Ruiz M., Royo G. Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid. Chemotherapy 2007, 53:397-401.